NUROFEN MELTLETS TABLETTIEN FARMAKOKINETIIKKA SELKÄLEIKATTAVILLA POTILAILLA

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-006302-29-FI

Enrollment

Registered

2007-01-22

Start date

2007-04-30

Completion date

Unknown

Last updated

2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tutkimuksen tavoitteena on selvittää suussa liukenevan ibuprofeenitabletin (Nurofen Meltlets 200mg) imeytymistä selkäleikatuilla potilailla heti leikkauksen jälkeen heräämössä. MedDRA version: 9.1 Level: LLT Classification code 10003983 Term: Back disorder

Interventions

Trade Name: Ibuprof von ct Amp Pharmaceutical Form: Injection* INN or Proposed INN: IBUPROFEN CAS Number: 15687271 Trade Name: Nurofen

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026